Heritage Cannabis Holdings Corp.

CANN

CA42727B1094

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 15:42:29 2024-04-08 EDT			5-day change	1st Jan Change
0.005 ^CAD	-.--%		-.--%	-66.67%

04-15	Heritage Cannabis Announces Commencement Of Sale And Investment Solicitation Process	MT
04-03	Heritage Cannabis Brief: Said Overnight It Obtained Creditor Protection to Pursue Restructuring and Sales Process	MT

Heritage Cannabis Holdings Corp. signed a letter of intent to acquire 20% stake in Stanley Park Digital Ltd for CAD 0.5 million.

January 15, 2018

Heritage Cannabis Holdings Corp. (CNSX:CANN) signed a letter of intent to acquire 20% stake in Stanley Park Digital Ltd for CAD 0.5 million on January 16, 2018. Pursuant to the terms, Heritage will pay CAD 0.25 million cash and issue CAD 0.25 million worth of shares.

Latest news about Heritage Cannabis Holdings Corp.

Heritage Cannabis Announces Commencement Of Sale And Investment Solicitation Process	04-15	MT
Heritage Cannabis Brief: Said Overnight It Obtained Creditor Protection to Pursue Restructuring and Sales Process	04-03	MT
Heritage Cannabis Holdings Corp. Reports Earnings Results for the Full Year Ended October 31, 2023	02-26	CI
Heritage Cannabis Holdings Corp. Announces New RAD Products, New Juicy Hoots Brand and Successful Adults Only Brand Performance	01-22	CI
Heritage Cannabis Holdings Corp. Brief: Closed Previously Announced Sale Lease Back Transaction and Third Amendment to its Senior Secured Loan	11-01	MT
Refile-- Heritage Cannabis Holdings Corp. Brief: Entered into binding agreements to sell the Co's real estate properties in Ontario and BC to BJK Developments Ltd. for a net purchase price of US$9,714,475 and lease them back	23-10-30	MT
Heritage Cannabis Holdings Corp. Brief: Entered into binding agreements to sell the Co's real estate properties in Ontario and BC to BJK Developments Ltd. for a net purchase price of $9,714,475 and lease them back	23-10-30	MT
Heritage Cannabis Holdings Corp. Brief: Announcing "Balance Sheet Transforming" Sale Lease Back Transaction and Third Amendment to its Senior Secured Loan	23-10-30	MT
Heritage Cannabis Begins Recreational Products Sales in New York	23-10-23	MT
Heritage Cannabis Holdings Corp. Officially Begins Sales in the Recreational Market in the State of New York	23-10-23	CI
Heritage Cannabis Holdings Corp. Announces the Purchase of an Additional Extraction Machine, Doubling Its Hydrocarbon Processing Capacity and Adding Eu Gmp Extraction Capabilities	23-10-11	CI
Heritage Cannabis Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-29	CI
Heritage Cannabis Holdings Corp. Appoints Jasmine Paige as Interim Chief Financial Officer	23-08-14	CI
Heritage Cannabis Begins Manufacturing for New York Recreational Market with Products Available in the State This August	23-07-18	CI
Heritage Cannabis Holdings Corp. Brief: Reporting gross revenue of $10,165,939 for the three months ended April 30, 2023; And Comprehensive loss of $1,958,047 or $0.00 loss per share	23-06-28	MT
Heritage Cannabis Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-28	CI
Heritage Cannabis Ships First Live Resin Products To Australia, Receives Additional Purchase Order	23-06-20	MT
Heritage Cannabis Holdings Corp. Ships First Live Resin Products to Australia and Receives Additional Purchase Order	23-06-20	CI
Heritage Cannabis Holdings Corp. Appoints Clinton Sharples, and Celine Arsenault as Directors	23-06-09	CI
BevCanna Enterprises Inc. Enters into Agreement with Heritage Cannabis Holdings Corp. for Sale and Distribution of its Cannabis-Infused Beverages in Canada	23-05-17	CI
Heritage Cannabis Teams Up With BevCanna to Enter Recreational Cannabis-Infused Beverage Market; Down 33.3%	23-05-17	MT
Heritage Cannabis Holdings Corp. Enters the Recreational Cannabis-Infused Beverage Vertical	23-05-17	CI
Heritage Cannabis Enters the New York Recreational Market with Products Available in the State This Summer	23-05-08	CI
Heritage Cannabis Receives First Purchase Order and Is Set to Begin Shipments of CBD Products to Brazil	23-04-03	CI
Heritage Cannabis Holdings Corp. Reports Earnings Results for the First Quarter Ended January 31, 2023	23-03-29	CI

Chart Heritage Cannabis Holdings Corp.

Duration

Period

More charts

Company Profile

Heritage Cannabis Holdings Corp. is a Canada-based cannabis company offering products to both the medical and recreational legal cannabis markets in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the United States. In Canada, it operates through its subsidiaries, Heritage Cannabis West Corporation (Heritage West) and Heritage Cannabis East Corporation (Heritage East). Heritage West holds a Health Canada issued cultivation, processing, and medical and adult use sales license, as well as an industrial hemp license, a cannabis oil sales license, and a cannabis research license. In the United States, it operates through, Opticann Inc., an oral and topical cannabinoid company.

Sector

Pharmaceuticals

Calendar

2024-09-24 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
HERITAGE CANNABIS HOLDINGS CORP.	-66.67%	3.71M
DONG-E-E-JIAO CO.,LTD.	+7.30%	4.69B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.08%	3.66B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.71%	3.11B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.32%	2.65B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.35%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+34.19%	1.78B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.49%	1.37B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.07%	1.39B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.38B

Alternative Medicine